ANTIGENIC variation in the brucei subgroup of trypanosomes considerably limits the development of a suitable anti-trypanosomal vaccine, and this limitation is likely to continue until we have more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback